General recommendation for assessment and management on the risk of glucocorticoid-induced osteonecrosis in patients with COVID-19

BACKGROUND/OBJECTIVE: Coronavirus disease 2019 (COVID-19) is a disaster in human medical history and glucocorticoids remain the most promising therapy. Osteonecrosis is a disease caused by reduced intraosseous blood flow to bones in the joints, which will rapidly induce joint destruction. Approximat...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wenlong, Huang, Zeqing, Tan, Biao, Chen, Gang, Li, Xugui, Xiong, Kan, Zhu, Ruizheng, Li, Ruihan, Li, Shuwen, Ye, Hengli, Liang, Zhi, Dong, Xiaojun, Zhou, Shijing, Chen, Song, Xi, Haixiang, Cheng, Hao, Xu, Rongpeng, Tu, Shenghao, Chen, Zhe, Qi, Lihua, Song, Jiandong, Xiao, Ruoran, Liu, Huilan, Nan, Qian, Yu, Huiyong, Cui, Hongsheng, Shen, Yanguang, Wang, Chengxiang, Lin, Na, Zhang, Yanqiong, Chen, Weiheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Speaking Orthopaedic Society 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526281/
https://www.ncbi.nlm.nih.gov/pubmed/34692412
http://dx.doi.org/10.1016/j.jot.2021.09.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526281/
https://www.ncbi.nlm.nih.gov/pubmed/34692412
http://dx.doi.org/10.1016/j.jot.2021.09.005

Ejemplares similares